| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | selumetinib:navitoclax (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.066 | 0.1 |
| mRNA | CH5424802 | GDSC1000 | pan-cancer | AAC | -0.064 | 0.1 |
| mRNA | foretinib | GDSC1000 | pan-cancer | AAC | 0.062 | 0.1 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | 0.1 | 0.1 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | 0.11 | 0.1 |
| mRNA | Sildenafil | CTRPv2 | pan-cancer | AAC | -0.069 | 0.1 |
| mRNA | Elesclomol | GDSC1000 | pan-cancer | AAC | 0.066 | 0.1 |
| mRNA | Bexarotene | CTRPv2 | pan-cancer | AAC | 0.064 | 0.1 |
| mRNA | ZSTK474 | CTRPv2 | pan-cancer | AAC | 0.066 | 0.1 |
| mRNA | OSI-930 | GDSC1000 | pan-cancer | AAC | 0.064 | 0.1 |